Targeting CDKs with Roscovitine Increases Sensitivity to DNA Damaging Drugs of Human Osteosarcoma Cells
Serena Vella(Istituto Ortopedico Rizzoli), Massimo Serra(Istituto Ortopedico Rizzoli)
Cited by 27
Related Papers
Frequency of Pathogenic Germline Variants in Cancer-Susceptibility Genes in Patients With Osteosarcoma
|JAMA Oncology|2020|251
Frequency and Implications of Chromosome 8 and 12 Gains in Ewing Sarcoma
|Cancer Genetics and Cytogenetics|1998|84
MicroRNA-101 is repressed by EZH2 and its restoration inhibits tumorigenic features in embryonal rhabdomyosarcoma
|Clinical Epigenetics|2015|41
Preclinical validation of Aurora kinases-targeting drugs in osteosarcoma
|British Journal of Cancer|2013|38